BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 10586212)

  • 1. Long-term immune recovery after CD34+ immunoselected and unselected peripheral blood progenitor cell transplantation: a case-control study.
    Laurenti L; Sica S; Sorà F; Piccirillo N; Ortu La Barbera E; Chiusolo P; Salutari P; Rumi C; Rutella S; Leone G
    Haematologica; 1999 Dec; 84(12):1100-3. PubMed ID: 10586212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune reconstitution after autologous hematopoietic stem cell transplantation in relation to underlying disease, type of high-dose therapy and infectious complications.
    Steingrimsdottir H; Gruber A; Björkholm M; Svensson A; Hansson M
    Haematologica; 2000 Aug; 85(8):832-8. PubMed ID: 10942930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell reconstitution after unmanipulated, CD8-depleted or CD34-selected nonmyeloablative peripheral blood stem-cell transplantation.
    Baron F; Schaaf-Lafontaine N; Humblet-Baron S; Meuris N; Castermans E; Baudoux E; Frère P; Bours V; Fillet G; Beguin Y
    Transplantation; 2003 Dec; 76(12):1705-13. PubMed ID: 14688520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of hematological and immunological function during long-term follow-up after peripheral blood stem cell transplantation.
    Laurenti L; Sica S; Salutari P; Rutella S; Serafini R; D'Onofrio G; Rumi C; Leone G
    Haematologica; 1998 Feb; 83(2):138-42. PubMed ID: 9549925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autografting of highly purified peripheral blood progenitor cells following myeloablative therapy in patients with lymphoma: a prospective study of the long-term effects on tumor eradication, reconstitution of hematopoiesis and immune recovery.
    Dreger P; Viehmann K; von Neuhoff N; Glaubitz T; Petzoldt O; Glass B; Uharek L; Rautenberg P; Suttorp M; Mills B; Mitsky P; Schmitz N
    Bone Marrow Transplant; 1999 Jul; 24(2):153-61. PubMed ID: 10455343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poor lymphocyte recovery following CD34-selected autologous peripheral blood stem cell transplantation for non-Hodgkin's lymphoma.
    Diviné M; Boutolleau D; Delfau-Larue MH; Beaujean F; Jouault H; Reyes F; Kuentz M; Bensussan A; Farcet JP; Boumsell L
    Br J Haematol; 1999 May; 105(2):349-60. PubMed ID: 10233403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid engraftment after allogeneic transplantation of density-enriched peripheral blood CD34+ cells in patients with advanced hematologic malignancies.
    Cao TM; Kusnierz-Glaz C; Valone F; Stockerl-Goldstein KE; Hu WW; Johnston L; Blume KG; Strober S; Negrin RS
    Cancer; 2001 Jun; 91(12):2205-13. PubMed ID: 11413507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of purified autologous peripheral blood CD34+ cells with low T cell content using CliniMACS device--a local experience.
    Leong CF; Habsah A; Teh HS; Goh KY; Fadilah SA; Cheong SK
    Malays J Pathol; 2008 Jun; 30(1):31-6. PubMed ID: 19108409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preliminary assessment of immune reconstitution after autologous peripheral hematopoietic stem cell transplantation (AHSCT)].
    Huang HQ; Cai QC; Shi YX; Lin XB; Wei J; Guo Y; Pan ZH
    Ai Zheng; 2006 Aug; 25(8):1023-8. PubMed ID: 16965687
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of lymphocyte and dendritic cell subsets after autologous CD34+ cell transplantation.
    Galy A; Rudraraju S; Baynes R; Klein J
    Bone Marrow Transplant; 2000 Jun; 25(12):1249-55. PubMed ID: 10871729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
    Witzens-Harig M; Heilmann C; Hensel M; Kornacker M; Benner A; Haas R; Fruehauf S; Ho AD
    Stem Cells; 2007 Jan; 25(1):228-35. PubMed ID: 17204607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children.
    Schwinger W; Weber-Mzell D; Zois B; Rojacher T; Benesch M; Lackner H; Dornbusch HJ; Sovinz P; Moser A; Lanzer G; Schauenstein K; Ofner P; Handgretinger R; Urban C
    Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
    Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
    Haematologica; 2000 Nov; 85(11):1165-71. PubMed ID: 11064469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of two different methods for CD34+ selection and T cell depletion in peripheral blood stem cell grafts--our experiences with CellPro, E rosetting and CliniMACS technique.
    Poloucková A; Vodvárková A; Kobylka P; Hrubá A; Gasová Z; Marinov I; Fales I; Sedlácek P; Kozák T; Starý J
    Neoplasma; 2001; 48(5):374-81. PubMed ID: 11845982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Kinetic study on the variety of lymphocytes and CD34+ cell subsets during autologous peripheral blood stem cell transplantation].
    Han XH; Shi YK; He XH; Yang JL; Liu P
    Zhonghua Zhong Liu Za Zhi; 2003 Jan; 25(1):47-50. PubMed ID: 12678987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution after allogeneic stem cell transplantation: the impact of stem cell source and graft-versus-host disease.
    Abrahamsen IW; Sømme S; Heldal D; Egeland T; Kvale D; Tjønnfjord GE
    Haematologica; 2005 Jan; 90(1):86-93. PubMed ID: 15642674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unrelated peripheral blood stem cell transplantation with 'megadoses' of purified CD34+ cells in three children with refractory severe aplastic anemia.
    Schwinger W; Urban C; Lackner H; Kerbl R; Benesch M; Dornbusch HJ; Sovinz P; Schauenstein K; Schumm M; Handgretinger R
    Bone Marrow Transplant; 2000 Mar; 25(5):513-7. PubMed ID: 10713628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effective T cell regeneration following high-dose chemotherapy rescued with CD34+ cell enriched peripheral blood progenitor cells in children.
    Heitger A; Kern H; Mayerl D; Maurer K; Nachbaur D; Frühwirth M; Fink FM; Niederwieser D
    Bone Marrow Transplant; 1999 Feb; 23(4):347-53. PubMed ID: 10100578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconstitution of T-cell repertoire after autologous stem cell transplantation: influence of CD34 selection and cytomegalovirus infection.
    Peggs KS; Verfuerth S; Pizzey A; Khan N; Moss P; Goldstone AH; Yong K; Mackinnon S
    Biol Blood Marrow Transplant; 2003 Mar; 9(3):198-205. PubMed ID: 12652471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunologic attributes of cytokine mobilized peripheral blood stem cells and recovery following transplantation.
    Talmadge JE; Reed EC; Kessinger A; Kuszynski CA; Perry GA; Gordy CL; Mills KC; Thomas ML; Pirruccello SJ; Letheby BA; Arneson MA; Jackson JD
    Bone Marrow Transplant; 1996 Jan; 17(1):101-9. PubMed ID: 8673041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.